Toxicokinetics & Pharmacokinetics
The study of toxicokinetics and pharmacokinetics plays a crucial role in drug development and safety assessment. Creative Bioarray offers a wide range of related resources, which allow researchers to evaluate the pharmacokinetic properties of drugs and assess their potential toxicity.
The 8 Costliest Mistakes in Preclinical CYP Phenotyping
Tag: Drug Metabolism, CYP Phenotyping
Details: A guide to the 8 common CYP phenotyping mistakes and how to fix them, improving ADME data, predicting DDIs, and accelerating preclinical drug development.
Reaction Phenotyping vs. Metabolic Stability
Tag: Drug Metabolism
Details: A concise comparison of Metabolic Stability and Reaction Phenotyping, highlighting their distinct purposes in drug development and providing clear guidance on when to apply each assay.
How to Interpret CYP Phenotyping Data
Tag: Drug Metabolism, CYP Phenotyping
Details: Step-by-step guidance on interpreting CYP phenotyping results to support DDI risk assessment and development decisions.
A Complete Guide to CYP Reaction Phenotyping in 2026
Tag: Drug Metabolism, CYP Phenotyping
Details: A practical guide explaining the purpose, methods, and application of CYP reaction phenotyping in drug development for effective DDI risk assessment.
6 Easy Steps to Get Your In Vitro ADME Done
Tag: ADME
Details: A practical 6-step workflow for planning, executing, and interpreting in vitro ADME assays to support early drug discovery and informed compound selection.
When Should You Introduce ADME Tox Testing in Drug Development?
Tag: ADME
Details: A stage-based ADME-Tox strategy highlighting key risk signals and integrated safety, PK, and potency insights to support better development decisions.
Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
Tag: ADME
Details: In vitro ADME assays are key to early drug discovery-but poor design can mislead project decisions. Learn the five critical pitfalls, from model selection to concentration choices, and see how to turn your ADME data into actionable insights.
In Vitro ADME vs In Vivo ADME
Tag: ADME
Details: A concise comparison of in vitro and in vivo ADME studies, explaining their respective roles, limitations, and how to use them together to support confident drug development decisions.
How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
Tag: ADME
Details: A practical guide to selecting the right in vitro ADME assays for small-molecule drug discovery, aligned with development stage, physicochemical properties, and translational decision-making.
What Is Genotoxicity in Pharmacology? Mechanisms and Sources
Tag: Genotoxicity
Details: Explore the molecular mechanisms behind genotoxicity and understand why assessing genetic risk is essential for safe drug discovery.
How Genotoxicity Testing Guides Safer Drug Development
Tag: Genotoxicity
Details: A practical overview of genotoxicity assays, regulatory considerations, and data interpretation for researchers and drug developers.
From Cells to Systems: Modern Approaches to Disease Modeling
Tag: Disease model
Details: An overview of disease modeling strategies, applications, and major challenges in preclinical research.
What Are the Best Methods to Test Cardiotoxicity?
Tag: Cardiotoxicity
Details: Explore the most widely used cardiotoxicity testing methods—including in vitro assays, in vivo models, and advanced imaging.
Why Cardiotoxicity Matters in R&D?
Tag: Cardiotoxicity
Details: Discover what cardiotoxicity is, the key biological mechanisms behind it, and why evaluating cardiotoxic risks is essential in modern drug development and safety testing.
Key Considerations in Toxicokinetic
Tag: Toxicokinetic
Details: This article briefly explores toxicokinetics studies from aspects such as dose selection, matrix selection, choice of animal models, and sample collection
Organ-on-a-Chip Systems for Drug Screening
Tag: Drug Screening
Details: Organ-on-a-chip systems are poised to play an instrumental role in the future of drug screening by offering more reliable and comprehensive models of human physiology.
How to Improve the Pharmacokinetic Properties of Peptides?
Tag: PK
Details: An array of strategies, such as amino acid substitution, side chain modifications, conjugation with polymers, modification of peptide termini, fusion to albumin, conjugation to the Fc portion of antibodies, stapled peptides, etc., have been employed to enhance the pharmacokinetic profiles of peptides.
Pharmacokinetics of Therapeutic Peptides
Tag: PK
Details: The pharmacokinetic profile of therapeutic peptides significantly influences their therapeutic efficacy and safety. Key aspects of peptide pharmacokinetics include absorption, distribution, metabolism, and elimination.
How to Improve Drug Distribution in the Brain
Tag: DMPK
Details: This article described various drug delivery and targeting strategies are currently being developed to enhance the transport and distribution of drugs into the brain.
Key Factors Influencing Brain Distribution of Drugs
Tag: DMPK
Details: The distribution of drugs can be significantly affected by distinct brain characteristics such as anatomy, physiological barriers, and cellular and biochemical composition.